Latest News

The FDA has approved Wockhardt’s cefepime and zidebactam, a novel intravenous antibiotic that targets multiple penicillin-binding proteins to treat adults with complicated urinary tract infections.

Nitrofurantoin achieved the highest clinical resolution rates among common UTI antibiotics.

These are the top 5 headlines you might have missed from May 2026.

For patients who express hesitancy about receiving multiple vaccines at once, Sonneveld pointed to the layered reassurance the evidence base now provides.

Esther H. Chung, MD, discusses how earlier fertility education, emotional screening, and structured referrals can improve patient experiences and outcomes in infertility care.

The Policy Center for Maternal Mental Health's 2026 report cards show a slight national grade improvement to a "C," though a new parental support domain returned an "F" across the United States.

A novel methylation signature may help identify patients unlikely to respond to progestin therapy, according to Hugh Taylor, MD.

Genevieve Neal-Perry, MD, PhD, highlights that phase 4 real-world data confirm that fezolinetant significantly reduces VMS bother, particularly in high-burden groups such as Black women and patients with obesity.

Progressive menstrual pain should prompt earlier evaluation for endometriosis to prevent missed opportunities and delayed care, Hugh Taylor, MD, explained.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

States with abortion restrictions saw increased expectant management and reliance on less effective treatment regimens for spontaneous abortion.

Expanding access and clinician education may enhance effectiveness of HPV self-collection programs.

Earlier initiation of conservative therapies may improve outcomes and reduce the need for advanced treatment in stress urinary incontinence.

Cervical cancer screening increased by 2.2 percentage points after program implementation, though 12.6% of eligible individuals received testing kits.

At ACOG, David Shalowitz, MD, highlighted the biggest takeaways from April's updated guidance on postmenopausal bleeding.

Early postpartum visits were associated with a 44% reduction in acute care use among patients with SUD, regardless of care model.

An at-home menstrual blood diagnostic platform in development may enable earlier, noninvasive detection of endometriosis.

A secondary analysis found that reduced time in target glucose range during labor was associated with increased adverse neonatal outcomes in gestational diabetes.

Sameena Rahman, MD, FACOG, asserts that the word "metabolic" in PMOS should fundamentally change clinical perceptions, transforming it from a GYN issue into a universally treated systemic condition.

After adjusting for the mother's mental health, a new meta-analysis found no significant association between common antidepressant use in pregnancy and autism or ADHD in chidlren.

Mifepristone via mail order and telehealth may continue after a Supreme Court ruling kept access in place while a lawsuit progresses.

Sameena Rahman, MD, FACOG, highlights that renaming PCOS to PMOS is vital for recognizing the condition as a systemic metabolic disorder rather than a simple ovarian issue.

A randomized clinical trial of 143 childbearing physicians found that a package including smart technology and mentorship significantly limited the rise of postpartum burnout.

“For families facing the fear of preterm birth, the absence of effective treatments for microbiome imbalance in the reproductive tract is devastating,” said Lynne Sykes, MD.

“The data show that Tdap vaccination during pregnancy is an effective way to protect infants from a serious disease at a time when they are most at risk," said Rochelle Walensky, MD, MPH.

Daré Bioscience reported that 1789 menstrual cycles of data have been reviewed for Ovaprene, with the DSMB recommending that the trial proceed without modifications.

Eduardo Lara-Torre, MD, FACOG, emphasizes that pediatric and adolescent gynecology provides a critical bridge to ensure young patients do not lose access to care as they transition to adult providers.

The vaginal insert will be available starting May 19, 2026.

According to a publication in The Lancet, a multistep process was used to generate a new name to avoid misleading references to ovarian cysts while accurately reflecting the condition's diverse features.

Elizabeth Alderman, MD, and Julie Samuels explain new research detailing what data exists for period poverty in high-income countries, as well as the lack of data on established interventions.

Eduardo Lara-Torre, MD, FACOG, explains that the unbundling of obstetric codes on January 1, 2027, will allow physicians to bill for each visit individually rather than receiving a single bundled payment.